Table 3 Results of measures of diagnostic performance (sensitivity and specificity) for each group studied based on the manufacturer’s recommendations of serological tests
Groups | Measures | ID screen® | Leiscan® | Leishmania 96® | IFAT | Speed Leish K® | |
|---|---|---|---|---|---|---|---|
Clinically sick infected dogs (n = 36) | Sensitivity | 0.972 | 0.972 | 0.972 | 1.000 | 0.917 | |
Clinically healthy infected dogs (n = 18) | 0.833 | 0.667 | 0.611 | 0.944 | 0.167 | ||
Seropositive infected dogs | High antibody levels (n = 34) | 1.000 | 1.000 | 1.000 | 0.882 | 0.853 | |
Medium antibody levels (n = 14) | 1.000 | 1.000 | 1.000 | 0.357 | 0.214 | ||
Low antibody levels (n = 5) | 0.800 | 0.800 | 1.000 | 1.000 | 0.000 | ||
Total (n = 53) | 0.981 | 0.981 | 1.000 | 0.750 | 0.604 | ||
Uninfected dogs from non-endemic area (n = 50) | Specificity | 1.000 | 1.000 | 1.000 | 0.940 | 1.000 | |
Uninfected dogs from endemic areas (n = 32) | 1.000 | 1.000 | 0.875 | 0.938 | 1.000 | ||
Dogs seropositive to other pathogens (n = 14) | 1.000 | 1.000 | 0.571 | 0.786 | 1.000 | ||